USPTO serial 98032973
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
R. Gwen Peterson
R. Gwen Peterson KILPATRICK TOWNSEND & STOCKTON LLP2175 NORTH CALIFORNIA BOULEVARDSUITE 600WALNUT CREEK, CA 94596| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; Diagnostic reagents and preparations, except for medical or veterinary use; Chemical reagents, other than for medical or veterinary purposes; Biological preparations, other than for medical or veterinary purposes, namely, for use in industry and science; Biochemical preparations for scientific purposes; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes | ACTIVE | Dec 29, 2023 |
| 005 | Preparations for detecting genetic predispositions for medical purposes; reagents for use in medical genetic testing. Enzyme preparations for medical purposes; Chemical pharmaceutical preparations for detecting genetic predispositions; Chemical reagents for medical or veterinary purposes | ACTIVE | Dec 29, 2023 |
| 009 | Analyzers for genome information, namely, laboratory devices for detecting genetic sequences, and recorded computer programs for scientific analysis of genetic sequences; nucleic acid sequencer for scientific purposes; gene amplification instrument for scientific purposes; DNA chips; diagnostic apparatus for the detection of pathogens for laboratory or research use; Recorded computer programs for biological data mining; Recorded computer programs for developing bioinformatics database for others; data processing apparatus; bio-chips for research or scientific purposes | ACTIVE | Dec 29, 2023 |
| 010 | Medical apparatus and instruments for detecting tumor cancer and genetic diseases; diagnostic testing apparatus for testing samples of body fluid, tissue and organ for medical use; diagnostic apparatus for the detection of cancer; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical apparatus and instruments for detecting and treating tumor and cancer; nucleic acid purification reagent kits comprised primarily of probes, buffers, and reagents for medical purposes; genome machine for medical purposes, namely, genetic sequencer for medical diagnostic purposes. | ACTIVE | Dec 29, 2023 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 13, 2026 | IUAF | USE AMENDMENT FILED | — |
| Apr 13, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 29, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 29, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 28, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 28, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 24, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 23, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 23, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 23, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 31, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 31, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 30, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 30, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 4, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 15, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 30, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 30, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 30, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 30, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 30, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 23, 2024 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 26, 2024 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 8, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2024 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 5, 2024 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 5, 2024 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 29, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 13, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 12, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 12, 2023 | NWAP | NEW APPLICATION ENTERED | — |